Anesthesia and analgesia
-
Anesthesia and analgesia · Sep 1999
Clinical Trial Controlled Clinical TrialThe preoperative administration of intravenous dextromethorphan reduces postoperative morphine consumption.
We evaluated the effect of dextromethorphan on postoperative pain management. Sixty ASA physical status I-III female patients undergoing major abdominal surgery underwent standardized general anesthesia. Thirty patients received an i.v. infusion of dextromethorphan 5 mg/kg before anesthetic induction (Pre group), whereas the remaining 30 patients received the same volume of isotonic sodium chloride solution, followed by a postoperative i.v. infusion of dextromethorphan 5 mg/kg (Post group). Patients in the Pre group received the same volume of isotonic sodium chloride solution postoperatively. All patients were then treated with patient-controlled i.v. analgesia, which administered a 0.6-mg bolus of morphine on demand (maximal 4 h dose 20 mg). The mean visual analog pain score during cough or movement and at rest were similar in the two groups in the first 3 days postoperatively. However, Post group patients consumed more morphine than Pre group patients during the first 2 days (P < 0.01). The sedation scores, patient satisfaction, and the incidence of morphine-related side effects were similar between the two groups. We conclude that the preoperative administration of dextromethorphan 5 mg/kg reduces postoperative morphine consumption compared with postoperative administration. ⋯ In this double-blinded study, we found that the preoperative administration of i.v. dextromethorphan 5 mg/kg, compared with postoperative administration, reduces postoperative morphine consumption, which may provide clinical evidence of preemptive or preventive analgesic effects of dextromethorphan.
-
Anesthesia and analgesia · Sep 1999
Randomized Controlled Trial Clinical TrialThe efficacy of a simulated intravascular test dose in sevoflurane-anesthetized children: a dose-response study.
A recent study demonstrated that changes in both heart rate (HR; positive if > or = 10bpm increase) and T-wave amplitude (positive if > or = 25% increase) reliably detect accidental intravascular injection when a full test dose containing epinephrine 0.5 microg/kg is injected intravascularly. We designed this study to prospectively determine whether a smaller dose of epinephrine would produce reliable HR and T-wave changes in sevoflurane-anesthetized children. We studied 80 ASA physical status I infants and children (6-72 mo) undergoing elective surgeries during 1.0 minimum alveolar anesthetic concentration sevoflurane and 67% nitrous oxide in oxygen. After the administration of i.v. atropine 0.01 mg/kg, the patients were randomly assigned to receive either i.v. saline (n = 20), an i.v. test dose (0.1 mL/kg) consisting of 1% lidocaine with 1:200,000 epinephrine (epinephrine 0.5 microg/kg group, n = 20), an i.v. test dose (0.05 mL/kg) (epinephrine 0.25 microg/kg group, n = 20), or an i.v. test dose (0.025 mL/kg) (epinephrine 0.125 microg/kg group, n = 20) via a peripheral vein to simulate the intravascular injection of the test dose. HR and systolic blood pressure were recorded every 20 and 30 s, respectively, and T-wave amplitude of lead II was continuously recorded for subsequent analysis. After the i.v. injection of the test dose, all children in the epinephrine 0.5 and 0.25 microg/kg groups developed positive responses based on the peak T-wave amplitude, whereas all children in the epinephrine 0.5 microg/kg group and 17 children (85%) in the epinephrine 0.25 microg/kg group elicited a positive response according to the peak HR criterion. No false-positive responses were observed with saline injections. Children in the epinephrine 0.125 microg/kg group showed clinically unacceptable efficacy based on either criterion. We conclude that the efficacies of detecting an intravascular injection of the test dose based on the hemodynamic and T-wave criteria are reduced with smaller doses of epinephrine and that HR and T-wave changes are still useful indicators in most patients if epinephrine 0.25 microg/kg is accidentally injected intravascularly. ⋯ To determine whether an epidurally administered local anesthetic has been unintentionally injected into a blood vessel, a small dose of epinephrine is often added to a local anesthetic. We found that an increase in T-wave amplitude > or = 25% in lead II and a heart rate increase > or = 10 bpm are useful indicators for detecting the accidental intravascular injection of a small dose of epinephrine in sevoflurane-anesthetized children.
-
Anesthesia and analgesia · Sep 1999
Randomized Controlled Trial Clinical TrialLevobupivacaine for ilioinguinal/iliohypogastric nerve block in children.
-
Anesthesia and analgesia · Sep 1999
Clinical TrialUse of abciximab-modified thrombelastography in patients undergoing cardiac surgery.
Thrombelastography (TEG) is a reliable coagulation monitoring system that can guide blood product transfusion in cardiac surgery. The maximum amplitude (MA) of TEG measures clot strength, which is dependent on both fibrinogen level and platelet function. Inhibition of platelet function with abciximab-fab is suggested to permit quantitative assessment of the contribution of fibrinogen to clot strength. We hypothesized that abciximab-modified TEG permits prediction of plasma fibrinogen levels and that the difference of standard MA and abciximab-modified MA (deltaMA) is a correlate for platelet function. We correlated abciximab-modified MA with plasma fibrinogen levels and deltaMA with platelet count in patients undergoing coronary revascularization. Correlation between plasma fibrinogen levels and abciximab-modified MA was significant (adjusted r2: 0.8; P < 0.0001). Correlation of deltaMA with platelet count was not significant when calculated in millimeters (adjusted r2: 0.04; P = 0.73). However, when deltaMA was calculated in dynes per square centimeter (deltaGMA), it correlated significantly with platelet count (adjusted r2: 0.51; P < 0.0001). We conclude that abciximab-modified TEG may therefore help to discriminate between hypofibrinogenemia and platelet dysfunction as a cause of decreased MA. ⋯ We examined the use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Modification of thrombelastography with abciximab-fab allows prediction of fibrinogen levels, despite coagulation altered by cardiac surgery. The difference of standard maximum amplitude and abciximab-modified maximum amplitude correlates with platelet function when expressed in dynes per square centimeter.
-
Anesthesia and analgesia · Sep 1999
The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.
Normal (hydrated) soda lime absorbent (approximately 95% calcium hydroxide [Ca(OH)2], the remaining 5% consisting of a mixture of sodium hydroxide [NaOH] and potassium hydroxide [KOH]) degrades sevoflurane to the nephrotoxin Compound A, and desiccated soda lime degrades desflurane, enflurane, and isoflurane to carbon monoxide (CO). We examined whether the bases in soda lime differed in their capacities to contribute to the production of these toxic substances by degradation of the inhaled anesthetics. Our results indicate that NaOH and KOH are the primary determinants of degradation of desflurane to CO and modestly augment production of Compound A from sevoflurane. Elimination of these bases decreases CO production 10-fold and decreases average inspired Compound A by up to 41%. These salutary effects can be achieved with only slight decreases in the capacity of the remaining Ca(OH)2 to absorb carbon dioxide. ⋯ The soda lime bases used to absorb carbon dioxide from anesthetic circuits can degrade inhaled anesthetics to compounds such as carbon monoxide and the nephrotoxin, Compound A. Elimination of the bases sodium hydroxide and potassium hydroxide decreases production of these noxious compounds without materially decreasing the capacity of the remaining base, Ca(OH)2, to absorb carbon dioxide.